These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1087 related items for PubMed ID: 29099760

  • 1. Symptom Severity Following Rifaximin and the Probiotic VSL#3 in Patients with Chronic Pelvic Pain Syndrome (Due to Inflammatory Prostatitis) Plus Irritable Bowel Syndrome.
    Vicari E, Salemi M, Sidoti G, Malaguarnera M, Castiglione R.
    Nutrients; 2017 Nov 03; 9(11):. PubMed ID: 29099760
    [Abstract] [Full Text] [Related]

  • 2. Chronic bacterial prostatitis and irritable bowel syndrome: effectiveness of treatment with rifaximin followed by the probiotic VSL#3.
    Vicari E, La Vignera S, Castiglione R, Condorelli RA, Vicari LO, Calogero AE.
    Asian J Androl; 2014 Nov 03; 16(5):735-9. PubMed ID: 24969056
    [Abstract] [Full Text] [Related]

  • 3. National Institutes of Health Chronic Prostatitis Symptom Index (NIH-CPSI) symptom evaluation in multinational cohorts of patients with chronic prostatitis/chronic pelvic pain syndrome.
    Wagenlehner FM, van Till JW, Magri V, Perletti G, Houbiers JG, Weidner W, Nickel JC.
    Eur Urol; 2013 May 03; 63(5):953-9. PubMed ID: 23141933
    [Abstract] [Full Text] [Related]

  • 4. Chronic prostatitis and small intestinal bacterial overgrowth: effect of rifaximin.
    Weinstock LB, Geng B, Brandes SB.
    Can J Urol; 2011 Aug 03; 18(4):5826-30. PubMed ID: 21854715
    [Abstract] [Full Text] [Related]

  • 5. Treatment of chronic prostatitis/chronic pelvic pain syndrome category IIIA with Serenoa repens plus selenium and lycopene (Profluss) versus S. repens alone: an Italian randomized multicenter-controlled study.
    Morgia G, Mucciardi G, Galì A, Madonia M, Marchese F, Di Benedetto A, Romano G, Bonvissuto G, Castelli T, Macchione L, Magno C.
    Urol Int; 2010 Aug 03; 84(4):400-6. PubMed ID: 20332612
    [Abstract] [Full Text] [Related]

  • 6. α-blockers, antibiotics and anti-inflammatories have a role in the management of chronic prostatitis/chronic pelvic pain syndrome.
    Thakkinstian A, Attia J, Anothaisintawee T, Nickel JC.
    BJU Int; 2012 Oct 03; 110(7):1014-22. PubMed ID: 22471591
    [Abstract] [Full Text] [Related]

  • 7. Eviprostat has an identical effect compared to pollen extract (Cernilton) in patients with chronic prostatitis/chronic pelvic pain syndrome: a randomized, prospective study.
    Iwamura H, Koie T, Soma O, Matsumoto T, Imai A, Hatakeyama S, Yoneyama T, Hashimoto Y, Ohyama C.
    BMC Urol; 2015 Dec 07; 15():120. PubMed ID: 26643109
    [Abstract] [Full Text] [Related]

  • 8. Treatment of refractory category III nonbacterial chronic prostatitis/chronic pelvic pain syndrome with intraprostatic injection of onabotulinumtoxinA: a prospective controlled study.
    Abdel-Meguid TA, Mosli HA, Farsi H, Alsayyad A, Tayib A, Sait M, Abdelsalam A.
    Can J Urol; 2018 Apr 07; 25(2):9273-9280. PubMed ID: 29680006
    [Abstract] [Full Text] [Related]

  • 9. Chronic Prostatitis/Chronic Pelvic Pain Syndrome is associated with Irritable Bowel Syndrome: A Population-based Study.
    Liao CH, Lin HC, Huang CY.
    Sci Rep; 2016 May 26; 6():26939. PubMed ID: 27225866
    [Abstract] [Full Text] [Related]

  • 10. Two-year experience with the german-translated version of the NIH-CPSI in patients with CP/CPPS.
    Schneider H, Brähler E, Ludwig M, Hochreiter W, Collins MF, Eremenco S, Weidner W.
    Urology; 2004 Jun 26; 63(6):1027-30. PubMed ID: 15183940
    [Abstract] [Full Text] [Related]

  • 11. High frequency of chronic bacterial and non-inflammatory prostatitis in infertile patients with prostatitis syndrome plus irritable bowel syndrome.
    Vicari E, La Vignera S, Arcoria D, Condorelli R, Vicari LO, Castiglione R, Mangiameli A, Calogero AE.
    PLoS One; 2011 Apr 08; 6(4):e18647. PubMed ID: 21494624
    [Abstract] [Full Text] [Related]

  • 12. Fluoxetine ameliorates symptoms of refractory chronic prostatitis/chronic pelvic pain syndrome.
    Xia D, Wang P, Chen J, Wang S, Jiang H.
    Chin Med J (Engl); 2011 Jul 08; 124(14):2158-61. PubMed ID: 21933619
    [Abstract] [Full Text] [Related]

  • 13. Curcumin and Fennel Essential Oil Improve Symptoms and Quality of Life in Patients with Irritable Bowel Syndrome.
    Portincasa P, Bonfrate L, Scribano ML, Kohn A, Caporaso N, Festi D, Campanale MC, Di Rienzo T, Guarino M, Taddia M, Fogli MV, Grimaldi M, Gasbarrini A.
    J Gastrointestin Liver Dis; 2016 Jun 08; 25(2):151-7. PubMed ID: 27308645
    [Abstract] [Full Text] [Related]

  • 14. Rifaximin treatment for the irritable bowel syndrome with a positive lactulose hydrogen breath test improves symptoms for at least 3 months.
    Meyrat P, Safroneeva E, Schoepfer AM.
    Aliment Pharmacol Ther; 2012 Dec 08; 36(11-12):1084-93. PubMed ID: 23066911
    [Abstract] [Full Text] [Related]

  • 15. Alfuzosin treatment for chronic prostatitis/chronic pelvic pain syndrome: a prospective, randomized, double-blind, placebo-controlled, pilot study.
    Mehik A, Alas P, Nickel JC, Sarpola A, Helström PJ.
    Urology; 2003 Sep 08; 62(3):425-9. PubMed ID: 12946740
    [Abstract] [Full Text] [Related]

  • 16. A randomized controlled trial of levofloxacin, terazosin, and combination therapy in patients with category III chronic prostatitis/chronic pelvic pain syndrome.
    Wang J, Yan D, Liang K, Xu Z.
    Int Urol Nephrol; 2016 Jan 08; 48(1):13-8. PubMed ID: 26577998
    [Abstract] [Full Text] [Related]

  • 17. The association of personality trait on treatment outcomes in patients with chronic prostatitis/chronic pelvic pain syndrome: an exploratory study.
    Koh JS, Ko HJ, Wang SM, Cho KJ, Kim JC, Lee SJ, Pae CU, Serretti A.
    J Psychosom Res; 2014 Feb 08; 76(2):127-33. PubMed ID: 24439688
    [Abstract] [Full Text] [Related]

  • 18. Impact of chronic prostatitis-like symptoms on the quality of life in a large group of men.
    Walz J, Perrotte P, Hutterer G, Suardi N, Jeldres C, Bénard F, Valiquette L, Karakiewicz PI.
    BJU Int; 2007 Dec 08; 100(6):1307-11. PubMed ID: 17941922
    [Abstract] [Full Text] [Related]

  • 19. The role of nutraceutical medications in men with non bacterial chronic prostatitis and chronic pelvic pain syndrome: A prospective non blinded study utilizing flower pollen extracts versus bioflavonoids.
    Maurizi A, De Luca F, Zanghi A, Manzi E, Leonardo C, Guidotti M, Antonaccio FP, Olivieri V, De Dominicis C.
    Arch Ital Urol Androl; 2019 Jan 18; 90(4):260-264. PubMed ID: 30655636
    [Abstract] [Full Text] [Related]

  • 20. Testosterone and Chronic Prostatitis/Chronic Pelvic Pain Syndrome: A Propensity Score-Matched Analysis.
    Lee JH, Lee SW.
    J Sex Med; 2016 Jul 18; 13(7):1047-55. PubMed ID: 27235281
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 55.